Evidence map›Paper›PMID 37954512›Full record

ArticleCurrent research in parasitology & vector-borne diseases2023

Field efficacy and safety of Felpreva® (tigolaner, emodepside and praziquantel) spot-on for the treatment of natural ear mite infestations (

Katrin Blazejak, Dejan Cvejić, Klaus Hellmann, Hannah Ringeisen, Hannah Hamburg, Gabriele Petry, Tanja N Knoppe, Norbert Mencke

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current research in parasitology & vector-borne diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. The most effective systemic treatment in cats with otodectic mange: A critically appraised topic.The Canadian veterinary journal = La revue veterinaire canadienne · 2025
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Katrin BlazejakVetoquinol S.A., 37 rue de la Victoire, 75009, Paris, France.
Dejan CvejićKlifovet GmbH, Geyerspergerstr. 27, 80689, Munich, Germany.
Klaus HellmannKlifovet GmbH, Geyerspergerstr. 27, 80689, Munich, Germany.
Hannah RingeisenElanco Animal Health, Alfred Nobel Str. 50, 40789, Monheim, Germany.
Hannah HamburgElanco Animal Health, Alfred Nobel Str. 50, 40789, Monheim, Germany.
Gabriele PetryElanco Animal Health, Alfred Nobel Str. 50, 40789, Monheim, Germany.
Tanja N KnoppeVet Advice, Dornstücken 25, 22607, Hamburg, Germany.
Norbert MenckeVetoquinol S.A., 37 rue de la Victoire, 75009, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The miticide efficacy of a single treatment with Felpreva® (tigolaner, emodepside and praziquantel) spot-on solution for cats was evaluated in two European field studies. One study was conducted in cats naturally infested with

Indexed as

CatEar mitesNotoedres catiNotoedric mangeOtodectes cynotisTigolaner

Identifiers

PMID37954512
PMCPMC10637875
OpenAlexW4386986478

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.